CN102336697A - Synthetic method for (2S,4S)-4-hydroxyproline - Google Patents

Synthetic method for (2S,4S)-4-hydroxyproline Download PDF

Info

Publication number
CN102336697A
CN102336697A CN201110192951XA CN201110192951A CN102336697A CN 102336697 A CN102336697 A CN 102336697A CN 201110192951X A CN201110192951X A CN 201110192951XA CN 201110192951 A CN201110192951 A CN 201110192951A CN 102336697 A CN102336697 A CN 102336697A
Authority
CN
China
Prior art keywords
hydroxyproline
compound method
iii
mol ratio
gets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201110192951XA
Other languages
Chinese (zh)
Inventor
柴宗曦
李建东
田苗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LANZHOU CHENXI BIO-TECHNOLOGY CO LTD
Original Assignee
LANZHOU CHENXI BIO-TECHNOLOGY CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LANZHOU CHENXI BIO-TECHNOLOGY CO LTD filed Critical LANZHOU CHENXI BIO-TECHNOLOGY CO LTD
Priority to CN201110192951XA priority Critical patent/CN102336697A/en
Publication of CN102336697A publication Critical patent/CN102336697A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Pyrrole Compounds (AREA)

Abstract

The invention provides a synthetic method for (2S,4S)-4-hydroxyproline, which belongs to the technical field of organic synthesis. The method comprises the following steps: (1) with (2S,4S)-4-hydroxyproline I as a raw material, carrying out carboxyl esterification so as to obtain II; (2) reacting Cbz-ous [(N-benzyloxycarbonyloxy)succinimide] with II to obtain nitrogen-protected III; (3) carrying out carboxyl esterification on III so as to obtain IV; (4) hydrolyzing ester groups of IV to obtain V; (5) removing Cbz groups from V so as to obtain VI, that is, (2S,4S)-4-hydroxyproline. The (2S,4S)-4-hydroxyproline prepared by the synthetic method in the invention has high purity and high yield; cost for raw materials used in the method is low; a few organic reagents are used, and little pollution and environmental protection are obtained.

Description

A kind of (2S, 4S)-the 4-Hydroxyproline compound method
Technical field
The present invention relates to a kind of organic cpds compound method.
Background technology
(2S, 4S)-4-Hydroxyproline is the midbody of a kind of very important medicine, agricultural chemicals and other chemicaladditivess.At present; Domestic also do not have industriallization to generate (2S; 4S)-technology of 4-Hydroxyproline; All be in theoretical investigation and laboratory development through most companies of data base querying such as Baidu library, Google, Chongqing dimension are general, cause shortcomings such as the synthesis technique productive rate is underground, purity is low, power consumption is big, cost height, and can't continue amplification and carry out suitability for industrialized production.
Summary of the invention
The technical problem that the present invention will solve is the defective that overcomes existing compound method, provide that a kind of productive rate is high, purity is high (2S, 4S)-4-Hydroxyproline suitability for industrialized production synthetic route.
Figure BSA00000535053600011
In order to solve the problems of the technologies described above, the invention provides following technical scheme:
A kind of (2S, 4S)-the 4-Hydroxyproline compound method, step is following,
(1) so that (2S 4R)-the 4-Hydroxyproline I is a raw material, carries out carboxyl esterification and gets II; (2) Cbz-ous (N-benzyl succinimdyl carbonate) and II react the III of nitrogen protection; (3) III is carried out hydroxy esterification and is got IV; (4) the IV ester hydrolysis gets V; (5) V is sloughed the basic VI that gets of Cbz.
Further, in the step (1), I and methanol solvate are at SOCl 2Effect down, ice bath carries out carboxyl esterification, reaction finish the back concentrate II, SOCl 2With the mol ratio of I be 1: (1~2).Preferably, SOCl 2With the mol ratio of I be 1: (1.3~1.7).
In the step (2), II is at Et 3Under N and methylene dichloride, trichloromethane or the Acetyl Chloride 98Min. solvency action, ice bath, with the Cbz-ous reaction, spissated III, the mol ratio of II and Cbz-ous are 1: (1.0~1.2).Preferably, the mol ratio of II and Cbz-ous is 1: (1.05~1.15).
In the step (3), III is in toluene or YLENE, diisopropyl azodiformate, at PPh 3Under the effect, ice bath generates IV with acetic acidreaction, and concentrated, crystallization gets IV, III and diisopropyl azodiformate, PPh 3Mol ratio be 1: (1.2~1.8).Preferably, III and diisopropyl azodiformate, PPh 3Mol ratio be 1: (1.4~1.6).
In the step (4), IV is in low-alcohol solution, and under sodium hydroxide or potassium hydroxide solution effect, hydrolysis generates V, and concentrated, crystallization gets V, and the mol ratio of IV and sodium hydroxide is 1: (3~4).Said lower alcohol is methyl alcohol, ethanol, Virahol etc.
In the step (5), under Pd/C catalysis, hydro-reduction gets VI.
Raw materials cost of the present invention is lower, all is kind common on the market, and raw materials quality meets corresponding national standards and gets final product; No particular requirement uses organic reagent few simultaneously, pollutes little; Environmental protection through the laboratory lab scale, gets into the pilot scale scale-up stage; Research and development and optimization through to synthesis technique can significantly reduce production costs; Internal price is lacked part company again up to more than 20 ten thousand yuan of per kilograms mostly at 30,000 yuan/kilogram at present, and the present invention produced (2S, 4S)-the 4-Hydroxyproline price is 2.4 ten thousand yuan/kilogram.
Description of drawings
Accompanying drawing is used to provide further understanding of the present invention, and constitutes the part of specification sheets, is used to explain the present invention with embodiments of the invention, is not construed as limiting the invention.In the accompanying drawings:
Fig. 1 be production of the present invention (2S, 4S)-the 4-Hydroxyproline process flow sheet;
Fig. 2 be the present invention produce (2S, 4S)-the nucleus magnetic resonance figure of 4-Hydroxyproline;
Fig. 3 is the purity liquid chromatographic detection figure that the present invention produces (2S, 48)-4-Hydroxyproline.
Embodiment
Below in conjunction with accompanying drawing the preferred embodiments of the present invention are described, should be appreciated that preferred embodiment described herein only is used for explanation and explains the present invention, and be not used in qualification the present invention.
Used experiment supplementary material of this embodiment and reagent are commercially available, particularly:
Raw material:
(2S, 4R)-4-Hydroxyproline, purity 98.0% molecular formula: C 5H 9NO 3, molecular weight 131.13, white plates crystallinity or crystalline powder are the unique sweet taste in the bitter taste, can improve the flavor matter of the local flavor of nectar, refreshment drink etc.Flavour is arranged, can make perfume material.274 ℃ of fusing points (decomposition), (25 ℃, 36.1%) soluble in water are slightly soluble in ethanol.
Auxiliary material:
SOCl 2(THIONYL CHLORIDE 97), molecular weight: 118.97 proterties: colourless to pale yellow or light red fuming liquid, the smell of suffocating is arranged, high refractivity is arranged, can be miscible with benzene, chloroform and tetrachloro, fusing point-104.5 ℃, 76 ℃ of boiling points, refractive index 1.517.
Et 3N (triethylamine), molecular formula: C 6H 15N relative molecular mass 101.19 colourless liquids can be miscible with ethanol, ether and the water below 18.7 ℃, is slightly soluble in the water more than 18.7 ℃, specific density 0.7255, fusing point-115 ℃.89~90 ℃ of boiling points, refractive index 1.4003, flash-point (closed-cup)-6 ℃, inflammable, medium poison is corrosive.
PPh 3(triphenylphosphine), molecular formula: C 18H 15P, outward appearance and proterties: white or light yellow plate crystal, molecular weight: 262.30, flash-point: 180 ℃/open cup; Fusing point: 79~82 ℃, boiling point: 377 ℃, solvability: water insoluble; Be slightly soluble in ethanol, be dissolved in benzene, acetone, tetracol phenixin, density: specific density (water=1) 1.32; Specific density (air=1) 9.0 white crystals, purity 99%.
Cbz-ous (N-benzyl succinimdyl carbonate), molecular formula: C 12H 11NO 5, molecular weight: 249.2226, white or off-white color crystalline powder, content:>=99%.
DIAD (diisopropyl azodiformate), molecular formula: C 8H 14N 2O 4, molecular weight: 202.21, density 1.02, fusing point 3-5 ℃, 75 ℃ of boiling points (0.2mmHg), specific refractory power 1.418-1.422,106 ℃ of flash-points.
Common agents: NaHCO 3, Na 2SO 4, methyl alcohol, salt solution etc. (required) according to experiment.
Laboratory apparatus: 2L, 3L, 5L single port bottle, the 20L bottle of answering back, magnetic agitation, TM, ice bath and oil bath system, Rotary Evaporators, condensing crystal system, suction filtration system etc.
With the listed proportioning of table 1, by the present invention's step shown in Figure 1 synthetic (2S, 4S)-4-Hydroxyproline, the yield of each embodiment is as shown in the table:
Figure BSA00000535053600041
Be example with embodiment 1 below, specify compound method of the present invention:
1, II is synthetic
Figure BSA00000535053600042
Figure BSA00000535053600051
Operation steps:
(1) in 3L single port bottle, adds I, 1.5L methyl alcohol, the ice bath cooling
(2) temperature begins to drip SOCl below 10 ℃ the time 2, temperature control makes temperature be no more than 50 ℃
(3) wait to dropwise the back oil bath, temperature rising reflux, reaction is spent the night;
Aftertreatment: with system directly concentrate II, yield (promptly 100%) is disregarded in reaction.
2, III is synthetic
Figure BSA00000535053600052
Operation steps:
In the 5L there-necked flask, add II, Et 3N and 1.8L DCM (methylene dichloride) stir, frozen water dissolving cooling, and temperature control slowly adds Cbz-ous (N-benzyl succinimdyl carbonate) below 20 ℃, the reaction stirred overnight;
Aftertreatment: add 1L moisture liquid and handle, the back uses 2N salt acid elution to be acidity to water PH, adds saturated NaHCO 3Wash salt washing, Na 2SO 4Drying, concentrate III, yield exceeds theoretical amount, in 100%.
3, IV is synthetic
Figure BSA00000535053600053
Figure BSA00000535053600061
Operation steps:
(1) in 3L single port bottle, adds III, 1L toluene, PPh 3Ice bath is cooled to below 5 ℃
(2) begin to splash into toluene, DIAD in the time of below the temperature to 5 ℃
(3) dropwise, changing oil to bathe is warming up to about 40 ℃, and reaction is spent the night;
Aftertreatment: the suction filtration white solid is abandoned it, and mother liquor concentrates and steams toluene.Use EA: PE=1 then: 5 crystallizations, suction filtration again, mother liquor concentrates, IV, yield exceeds theoretical amount, by 100%.
4, V is synthetic
Figure BSA00000535053600062
Operation steps:
, 20L adds IV in answering back bottle, methyl alcohol and 1N aqueous sodium hydroxide solution stirring reaction 3-4 hour;
Aftertreatment: system is concentrated, suction filtration, filter cake is abandoned it, and extracting impurities is to only containing small amount of impurities under alkaline condition, and acid adjustment is used the EA extraction product to there being a large amount of white solids to separate out (pH=1-2), the saturated common salt water washing, NaSO4 is dry, concentrates.Add EA: pH=1: 8 crystallization gained filter cakes are used EA: PE=1 again: 3 washings, dry to such an extent that white-yellowish solid V 160 restrains (yield is 56.5%).
5, VI is synthetic
Figure BSA00000535053600063
Operation steps:
In 2L single port bottle, add V, Pd/C, ventilation add H 2, about reaction 18h, (note: bleed once every separated half a hour);
Aftertreatment: elimination Pd/C, mother liquor concentrates, and the gained solid with EA washing 3 times, is washed 2 times with methyl alcohol again, gets finished product VI 92.1g (yield is 93.3%).
Embodiment 1 products therefrom is carried out magnetic resonance detection (deuterochloroform is a solvent), and spectrogram is as shown in Figure 2, wherein, NMR (CDCl3,400MHZ) δ: 2.13 (m, 1H), 2.35 (m, 1H), 3.37 (m, 2H), 4.05 (m, 1H), 4.44 (m, 1H); The liquid chromatogram explanation products obtained therefrom purity of Fig. 3 is greater than 94% (testing conditions, moving phase: methyl alcohol (100%), wavelength: 254nm, sample size: 10ul, flow: 1ml/min).
What should explain at last is: the above is merely the preferred embodiments of the present invention; Be not limited to the present invention; Although the present invention has been carried out detailed explanation with reference to previous embodiment; For a person skilled in the art, it still can be made amendment to the technical scheme that aforementioned each embodiment put down in writing, and perhaps part technical characterictic wherein is equal to replacement.All within spirit of the present invention and principle, any modification of being done, be equal to replacement, improvement etc., all should be included within protection scope of the present invention.

Claims (9)

1. one kind (2S, 4S)-the 4-Hydroxyproline compound method, it is characterized in that: step is following,
Figure FSA00000535053500011
(1) so that (2S 4R)-the 4-Hydroxyproline I is a raw material, carries out carboxyl esterification and gets II; (2) N-benzyl succinimdyl carbonate and II react the III of nitrogen protection; (3) III is carried out hydroxy esterification and is got IV; (4) the IV ester hydrolysis gets V; (5) V is sloughed the basic VI that gets of Cbz.
It is 2. according to claim 1 that a kind of (2S, 4S)-the 4-Hydroxyproline compound method, it is characterized in that: in the said step (1), I and methanol solvate are at SOCl 2Effect down, ice bath carries out carboxyl esterification, reaction finish the back concentrate II, SOCl 2With the mol ratio of I be 1: (1~2).
3. according to claim 2 a kind of (2S 4S)-the 4-Hydroxyproline compound method, is characterized in that: in the said step (1), SOCl 2With the mol ratio of I be 1: (1.3~1.7).
It is 4. according to claim 1 that a kind of (2S, 4S)-the 4-Hydroxyproline compound method, it is characterized in that: in the said step (2), II is at Et 3Under N and methylene dichloride, trichloromethane or the Acetyl Chloride 98Min. solvency action, ice bath, with the reaction of N-benzyl succinimdyl carbonate, spissated III, the mol ratio of II and Cbz-ous N-benzyl succinimdyl carbonate is 1: (1.0~1.2).
It is 5. according to claim 4 that a kind of (2S, 4S)-the 4-Hydroxyproline compound method, it is characterized in that: in the said step (2), the mol ratio of II and Cbz-ous is 1: (1.05~1.15).
It is 6. according to claim 1 that a kind of (2S 4S)-the 4-Hydroxyproline compound method, is characterized in that: in the said step (3), III is in toluene or YLENE, diisopropyl azodiformate, at PPh 3Under the effect, ice bath generates IV with acetic acidreaction, and concentrated, crystallization gets IV, III and diisopropyl azodiformate, PPh 3Mol ratio be 1: (1.2~1.8).
7. according to claim 6 a kind of (2S 4S)-the 4-Hydroxyproline compound method, is characterized in that: in the said step (3), III and diisopropyl azodiformate, PPh 3Mol ratio be 1: (1.4~1.6).
8. a kind of (2S according to claim 1; 4S)-and the 4-Hydroxyproline compound method, it is characterized in that: in the said step (4), IV is in low-alcohol solution; Under sodium hydroxide or potassium hydroxide solution effect; Hydrolysis generates V, and concentrated, crystallization gets V, and the mol ratio of IV and sodium hydroxide is 1: (3~4).
It is 9. according to claim 1 that a kind of (2S, 4S)-the 4-Hydroxyproline compound method, it is characterized in that: in the said step (5), under Pd/C catalysis, hydro-reduction gets VI.
CN201110192951XA 2011-07-12 2011-07-12 Synthetic method for (2S,4S)-4-hydroxyproline Pending CN102336697A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110192951XA CN102336697A (en) 2011-07-12 2011-07-12 Synthetic method for (2S,4S)-4-hydroxyproline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110192951XA CN102336697A (en) 2011-07-12 2011-07-12 Synthetic method for (2S,4S)-4-hydroxyproline

Publications (1)

Publication Number Publication Date
CN102336697A true CN102336697A (en) 2012-02-01

Family

ID=45512697

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110192951XA Pending CN102336697A (en) 2011-07-12 2011-07-12 Synthetic method for (2S,4S)-4-hydroxyproline

Country Status (1)

Country Link
CN (1) CN102336697A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105294532A (en) * 2015-12-07 2016-02-03 四川同晟氨基酸有限公司 Preparation method of L-hydroxyproline

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912230A (en) * 1988-09-16 1990-03-27 E. R. Squibb & Sons, Inc. Process for stereochemically inverting a hydroxy function of an ester by a modified Mitsunobu reaction process
CN101193852A (en) * 2005-02-18 2008-06-04 因诺迪亚有限公司 Analogs of 4-hydroxyisoleucine and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912230A (en) * 1988-09-16 1990-03-27 E. R. Squibb & Sons, Inc. Process for stereochemically inverting a hydroxy function of an ester by a modified Mitsunobu reaction process
CN101193852A (en) * 2005-02-18 2008-06-04 因诺迪亚有限公司 Analogs of 4-hydroxyisoleucine and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANTHONY G.M. BARRETT,等: "Electrochemical Oxidation of Proline Derivatives: Total Syntheses of Bulgecinine and Bulgecin C", 《J. ORG. CHEM.》 *
MASAHIKO SEKI,等: "A convenient synthesis of (2S,4S)-4-hydroxyproline", 《BIOSCI. BIOTECH. BIOCHEM.》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105294532A (en) * 2015-12-07 2016-02-03 四川同晟氨基酸有限公司 Preparation method of L-hydroxyproline
CN105294532B (en) * 2015-12-07 2018-03-06 四川同晟氨基酸有限公司 A kind of preparation method of L hydroxy-prolines

Similar Documents

Publication Publication Date Title
CN107108640A (en) The synthesis of bruton's tyrosine kinase inhibitor
CN104447868B (en) A kind of preparation method of tenofovir disoproxil fumarate
CN102408437A (en) Preparation method for Aspoxicillin
CN102351933B (en) Method for preparing hydroxycobalamin salt
CN104211599B (en) Many alkoxyls substituted 2,3-dicarboxylic ester benzophenanthrene and preparation method thereof
CN114560901A (en) Preparation method of ergosterol or derivative thereof
CN114685485B (en) Synthesis method of pyridoimidazole thiopropionic acid anti-gout compound
CN101531654A (en) Preparation method for Rupatadine
CN102336697A (en) Synthetic method for (2S,4S)-4-hydroxyproline
CN108658805B (en) Preparation method of asymmetric azobenzene
CN102267898A (en) Method for preparing diethyl succinate by using pyridine ionic liquid as catalyst
CN109912553A (en) A kind of intermediate and preparation method thereof
CN113024411B (en) Preparation method of tralkoxydim
CN101362678B (en) Methylation reaction method
CN107715909A (en) A kind of Proline-Catalyzed agent of pentaerythrite support and preparation method and application
CN113214094A (en) Synthetic method of voglibose
CN105461718A (en) 5-Bromo-7-azaindole synthesis process
CN102260236B (en) Preparation method of coumarin compounds
CN102351775B (en) Preparation method of levo-5-hydroxytryptophan
CN110003180A (en) Pyrroles-pyridine-pyrrole class compound post-processing purification process
CN102911085A (en) Synthesis process of compound D-2- aminoxy-3-methylbutyric acid
CN114702483B (en) Preparation and purification method of 2-substituted-10- (benzotriazole) -9-thioxanthene
CN114456085B (en) Preparation method and application of 2-azido-3-hydroxypropionic acid
CN101906115A (en) Preparation method of beta-methyl carbapenem antibiotic intermediate
CN105111125B (en) A kind of synthetic method of pharmaceutical intermediate condensed hetero ring ketone compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120201